Nov. 18, 2005 — The U.S. Food and Drug Administration (FDA) has warned healthcare professionals regarding the increased risk of severe asthma episodes and death associated with use of inhalation ...

Salmeterol (as xinafoate) 50mcg/inh; dry pwd for inhalation; device with drug in blisters. Serevent Diskus is supplied as a disposable teal green plastic inhaler containing a foil blister strip with ...

The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. SEREVENT ACCUHALER contains the active ingredient salmeterol xinafoate ...

During a senate hearing, convened following the withdrawal of Merck & Co.'s COX-2 Vioxx (rofecoxib) in September, the FDA's David Graham commented that the safety profile of five other currently ...

GlaxoSmithKline is in the firing line again after a letter published in The Lancet accused the firm of misleading regulators over clinical data for its asthma compound, Serevent (salmeterol), which is ...

Scientists of a U.S. government-funded asthma study had to spend nearly $1 million of taxpayers' money after British drugmaker GlaxoSmithKline PLC declined to donate its asthma drug and look-alike ...

Boehringer Ingelheim and co-marketer Pfizer could make a bid to capture more of the respiratory drug market. In a new study, the company's Spiriva drug proved as effective as GlaxoSmithKline's ...

Reason for posting: A large, placebo-controlled trial of Serevent (salmeterol), a long-acting β 2-receptor agonist (LABA), was recently stopped early amid concerns that the drug may be associated with ...

LOS ANGELES (AP) — Researchers say they've found a possible new treatment for adults with hard-to-control asthma. A federally funded study found that Spiriva, which is used to treat emphysema and ...